iSBTc 22nd Annual Meeting

Annual Meeting Main Page   |   Award Winners   |   Download Final Program
CME Information   |   Documents & News Releases   |   Presentation Slides & Schedule
Faculty   |   Pictures   |   Download Abstracts

November 2 - 4, 2007
Seaport World Trade Center
Boston, Massachusetts

Sunday Presentations
Slides for select presentations below have been provided by the corresponding speaker for your convenience.
Please click the Click to view presentation next to the speaker's name for the slides you wish to view.

Schedule at a Glance  |  Presentations  |  Friday Presentations  |  Saturday Presentations  |  Sunday Presentations

Sunday, November 4
8:00 am - 8:45 am Update: 2006 Mini-Symposium Update
Chair:
George Coukos, MD, PhD - University of Pennsylvania Medical Center

Speaker:
Click to view presentationMichael B. Atkins, MD - Beth Israel Deaconess Medical Center
8:30 am - 8:45 am Update: National Cancer Institute Immunotherapy Agent Workshop
Click to view presentationMartin A. Cheever, MD - Fred Hutchinson Cancer Research Center
8:45 am - 11:00 am Plenary Session: Vaccines / Dendritic Cells
Co-Chair:
Mary L. Disis, MD - University of Washington
Lothar H. Finke, MD - ARGOS Therapeutics
8:45 am - 9:15 am The Development of Provenge® (Sipuleucel-T) an Active Cellular
Immunotherapy for Prostate Cancer
Click to view presentationDavid L. Urdal, PhD - Dendreon Corporation
9:15 am - 9:30 am Long-Term Survival in Patients with Metastatic Melanoma Vaccinated
with Melanoma-Antigen Loaded Dendritic Cells
Click to view presentationJoseph W. Fay, MD - Baylor University Medical Center
9:30 am - 9:45 am Phase II Trial of a 10-Epitope CTL Vaccine, IDM-2101, in
Metastatic NSCLC Patients: Induction of Immune Responses and Clinical Efficacy
Minal Barve, MD - Mary Crowley Cancer Research Centers
9:45 am - 10:00 am Different DC Populations Interact with Memory & Effector T Cells, or with Treg Cells
Pawel Kalinski, MD, PhD - University of Pittsburgh Cancer Institute
10:00 am - 10:15 am Features of Lympoid Neogenesis After Dermal Injection of Incomplete Freund’s Adjuvant with or without Peptides
Craig L. Slingluff, Jr., MD - University of Virginia
10:15 am - 10:30 am IMA901, a Novel Multi-Peptide Vaccine for the Treatment of Renal
Cell Carcinoma - Pre-Clinical and Clinical Studies and Implications for Combination with Other Agents
Click to view presentationHarpreet Singh, PhD - Immatics Biotechnologies GmbH
10:30 am - 11:00 am Insulin like Growth Factor Receptor Family Members: Essential Tumor Antigens in Breast Cancer
Click to view presentationMary L. Disis, MD - University of Washington
11:00 am - 11:15 am Refreshment Break
11:15 am - 12:45 pm Hot Topic Sessions: Vaccines / Dendritic Cells
Moderators:
Bernard A. Fox, PhD - Earle A. Chiles Research Institute
Jon M. Wigginton, MD - Merck & Co., Inc.

Participants:
Click to view presentationBrent A. Blumenstein, PhD - TriArc Consulting
Click to view presentationLee S. Simon, MD - Beth Israel Deaconess Medical Center
Click to view presentationCharles Drake, MD, PhD - Johns Hopkins University
Click to view presentationDavid L. Urdal, PhD - Dendreon Corporation
James W. Young, MD - Memorial Sloan-Kettering Cancer Center
12:45 pm Meeting Adjourns

Creative Commons License
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.